Content area

|
|

Nye psykoaktive stoffer kræver et paradigmeskifte i misbrugstestning i Danmark

Forfatter(e)
Torben Breindahl1, Peter Hindersson1, Peter Derek Christian Leutscher2, 3 & Andreas Kimergård4 1) Klinisk Biokemisk Afsnit, Regionshospital Nordjylland 2) Center for Klinisk Forskning, Regions-hospital Nordjylland 3) Klinisk Institut, Aalborg Universitet 4) National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London Ugeskr Læger 2018;180:V07170564
Reference: 
Ugeskr Læger 2018;180:V07170564
Blad nummer: 
Sidetal: 
2-7
New psychoactive substances require a paradigm shift in drug testing in Denmark
The emergence of an increasing number of new psychoactive substances (NPS) on the drug market requires a paradigm shift in drug testing. Immunoassay screening needs to be replaced with highly specific and sensitive analytical methods based on chromatography and mass spectrometry to produce accurate results, promote health and patient safety and collect data on the prevalence of NPS use, impact on public health and clinical aspects of NPS in Denmark. Development and implementation of new analytical methods currently present a major challenge for both clinical and forensic laboratories.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anne Gersdorff Korsgaard | 20/10
1 Kommentar
af Karen Brink Linnet | 19/10
1 Kommentar
af Thor Andersen Knudsen | 19/10
2 kommentarer
af Ole Lindgård Dollerup | 18/10
1 Kommentar
af Kristine Rasmussen | 18/10
1 Kommentar
af Camilla Bang | 16/10
1 Kommentar
af Tobias Ramm Eberlein | 15/10
6 kommentarer
af Frank Bang Nissen | 15/10
1 Kommentar